SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-008543
Filing Date
2020-08-06
Accepted
2020-08-05 21:56:40
Documents
8
Period of Report
2020-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_aug2020.htm 8-K 45447
2 UNDERWRITING AGREEMENT ex1-1.htm EX-1.1 274389
3 OPINION OF DISCLOSURE LAW GROUP, A PROFESSIONAL CORPORATION ex5-1.htm EX-5.1 10022
4 PRESS RELEASE ex99-1.htm EX-99.1 11271
5 PRESS RELEASE ex99-2.htm EX-99.2 11539
6 PRESS RELEASE ex99-3.htm EX-99.3 16815
7 IMAGE dlg.jpg GRAPHIC 8493
8 IMAGE vistagen.jpg GRAPHIC 4408
  Complete submission text file 0001654954-20-008543.txt   388755
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 201079563
SIC: 2834 Pharmaceutical Preparations